Tenax Therapeutics, Inc.

TENX·NasdaqCM·Healthcare
Compare
1.8100−0.0300 (−1.63%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market1.7900−0.0200 (−1.10%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1.8400
Open1.8500
Day range1.73501.8800
52-week range1.310019.4000
Off day high−3.72%
Off 52-week high−90.67%
Volume1.24M
Avg. volume (3M)5.65M
Market cap67.74M
EPS (TTM)-1.48
Forward P/E-1.21
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.92
Shares outstanding37.42M
Short interest19.48% of float
Earnings dateAug 11, 2025 (est.)
Analyst target9.6250
Profit margin0.00%

Against its peers

Compare in full ›
TENX TNXP TNYA PTX.AX RVX.TO RNTX
Market cap 67.74M 87.64M 84.31M 60.62M 27.54M 56.82M
P/E (TTM) — — — — — —
Forward P/E -1.2 -0.7 -0.9 5.3 — —
Price/book 0.8 0.4 1.2 3.8 -0.2 5.5
Dividend yield — — — — — —
1-year change −73.84% −71.36% −72.59% +10.87% −20.00% −57.99%
Today −1.63% −1.54% +2.66% +3.92% +6.67% −1.32%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

Latest news

All TENX news ›
Stock Titan·

Olema Pharmaceuticals: BVF reports roughly 9.8% stake

A 9.99% ownership cap limits warrant exercises at Olema Pharmaceuticals (OLMA). Stock Titan - [SCHEDULE 13D/A] Olema Pharmaceuticals, Inc. Amended Major Shareholder Report Olema Pharmaceuticals: BVF reports roughly 9.8% stake A 9.99%…

Stock Titan·Negative

Tenax Therapeutics: Millennium reports 3.6% stake

Three parties each report 1.36M shares of Tenax Therapeutics (TENX). Stock Titan - [SCHEDULE 13G/A] TENAX THERAPEUTICS, INC. Amended Passive Investment Disclosure Tenax Therapeutics: Millennium reports 3.6% stake The cover pages report…

StocksToTrade·Negative

TENX Stock Drifts Lower As Traders Eye Cash Runway

Tenax Therapeutics Inc. stocks have been trading down by -8.47 percent after mixed trial data fueled renewed investor uncertainty. Key Takeaways TENX has slipped from the $1.90 area to around $1.68, showing a controlled pullback rather…

StocksToTrade·Negative

TENX Stock Drifts Lower As Traders Watch Tight Range

Tenax Therapeutics Inc. stocks have been trading down by -8.47 percent amid bearish sentiment over its latest clinical trial setback. TENX is a classic development-stage biotech: lots of runway, no profits yet. Tenax Therapeutics Inc.…

Stock Titan·

Tenax Therapeutics pauses LEVEL-2 trial enrollment

The LEVEL-2 pause is intended to allow stricter enrollment criteria based on baseline walking distance and right atrial volume. In the completed LEVEL Phase 3 trial, levosimendan did not meet its primary endpoint: the Week 12 6MWD…

From the 4Search news index, newest first.

In the news

11mentions in 30 days
8with it in the headline
Negativesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance